Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases.

P53 immunohistochemical detection using DO7 antibody on 942 cases of previously untreated breast invasive ductal carcinoma (IDC) with a median follow up of 117.9 months (89 to 160) was performed.